RXI Pharma (RXII) Announces Receipt of USPTO Notice of Allowance Covering sd-rxRNA Technology
Tweet Send to a Friend
RXI Pharma (NASDAQ: RXII) announced that it has been granted a Notice of Allowance from the United States Patent and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
